{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T01:53:09Z","timestamp":1792979589431,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.yrtph.2010.12.007","type":"journal-article","created":{"date-parts":[[2011,1,7]],"date-time":"2011-01-07T04:30:10Z","timestamp":1294374610000},"page":"385-390","source":"Crossref","is-referenced-by-count":399,"title":["Uniform assessment and ranking of opioid Mu receptor binding constants for selected opioid drugs"],"prefix":"10.1016","volume":"59","author":[{"given":"Donna A.","family":"Volpe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grainne A. McMahon","family":"Tobin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Daniel","family":"Mellon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aspandiar G.","family":"Katki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Colatsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Kropp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Leigh","family":"Verbois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2010.12.007_b0005","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0022-3565(24)37585-8","article-title":"Stimulation of guanosine-5\u2032-O-(3-(35S)thio)triphosphate binding by endogenous opioids acting at a cloned Mu receptor","volume":"286","author":"Alt","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.yrtph.2010.12.007_b0010","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.watres.2008.11.056","article-title":"Monitoring of opiates, cannabinoids and their metabolites in wastewater, surface water and finished water in Catalonia, Spain","volume":"43","author":"Boleda","year":"2009","journal-title":"Water Res."},{"key":"10.1016\/j.yrtph.2010.12.007_b0015","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1124\/dmd.106.009746","article-title":"In vivo blood-brain barrier transport of oxycodone in the rat: indications for active influx and implications for pharmacokinetics\/pharmacodynamics","volume":"34","author":"Bostr\u00f6m","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.yrtph.2010.12.007_b0020","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/ALN.0b013e318164cf9e","article-title":"Blood\u2013brain barrier transport helps to explain discrepancies in in vivo potency between oxycodone and morphine","volume":"108","author":"Bostr\u00f6m","year":"2008","journal-title":"Anesthesiology"},{"key":"10.1016\/j.yrtph.2010.12.007_b0025","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0022-3565(24)37503-2","article-title":"Fentanyl and its analogs desensitize the cloned mu opioid receptor","volume":"285","author":"Bot","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.yrtph.2010.12.007_b0030","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejphar.2008.09.043","article-title":"A pharmacological comparison of the cloned frog and human Mu opioid receptors reveals differences in opioid affinity and function","volume":"599","author":"Brasel","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.yrtph.2010.12.007_b0035","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1476-5381.1988.tb11569.x","article-title":"The physiological relevance of low agonist affinity binding at opioid \u03bc-receptors","volume":"94","author":"Carroll","year":"1988","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.yrtph.2010.12.007_b0040","doi-asserted-by":"crossref","first-page":"4469","DOI":"10.1073\/pnas.77.8.4469","article-title":"Possible role of distinct morphine and enkephalin receptors in mediating actions of benzomorphan drugs (putative \u03ba and \u03c3 agonists)","volume":"77","author":"Chang","year":"1980","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.yrtph.2010.12.007_b0045","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0024-3205(93)90152-S","article-title":"The opioid receptor binding of dezocine, morphine, fentanyl, butorphanol and nalbuphine","volume":"52","author":"Chen","year":"1993","journal-title":"Life Sci."},{"key":"10.1016\/j.yrtph.2010.12.007_b0050","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/0024-3205(91)90150-A","article-title":"Mu receptor binding of some commonly used opioids and their metabolites","volume":"48","author":"Chen","year":"1991","journal-title":"Life Sci."},{"key":"10.1016\/j.yrtph.2010.12.007_b0055","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (IC50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.yrtph.2010.12.007_b0060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0014-2999(79)90142-0","article-title":"Opiate receptor binding affected differentially by opiates and opioid peptides","volume":"55","author":"Childers","year":"1979","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.yrtph.2010.12.007_b0065","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0885-3924(98)00094-3","article-title":"Peak plasma concentrations after oral morphine: a systemic review","volume":"16","author":"Collins","year":"1998","journal-title":"J. Pain. Symp. Manage."},{"key":"10.1016\/j.yrtph.2010.12.007_b0070","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s002280050651","article-title":"Relative potency of controlled-release oxycodone and controlled-release morphine in a postoperative pain model","volume":"55","author":"Curtis","year":"1999","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.yrtph.2010.12.007_b0075","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.jpba.2005.04.049","article-title":"Development and validation of a radioreceptor assay for the determination of morphine and its active metabolites in serum","volume":"39","author":"de Jong","year":"2005","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.yrtph.2010.12.007_b0080","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0022-3565(25)20761-3","article-title":"Characterization of opioid agonist efficacy in a C6 glioma cell line expressing the \u03bc opioid receptor","volume":"278","author":"Emmerson","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.yrtph.2010.12.007_b0085","unstructured":"FDA. Disposal by Flushing of Certain Unused Medicines: What You Should Know. August 2010. <http:\/\/www.fda.gov\/Drugs\/ResourcesForYou\/Consumers\/BuyingUsingMedicineSafely\/EnsuringSafeUseofMedicine\/SafeDisposalofMedicines\/ucm186187.htm>. Accessed 9\/8\/10."},{"key":"10.1016\/j.yrtph.2010.12.007_b0090","first-page":"446","article-title":"Analgetic activity of alpha-1-(1-methyl-3-pyrrolidinyl)-1-phenylpropyl propionate fumarate (AHR-1767)","volume":"178","author":"Funderburk","year":"1969","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.yrtph.2010.12.007_b0095","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s002100000266","article-title":"Affinity, potency and efficacy of tramadol and its metabolites at the cloned human mu-opioid receptor","volume":"362","author":"Gillen","year":"2000","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.yrtph.2010.12.007_b0100","series-title":"Goodman & Gilman\u2019s the Pharmacological Basis of Therapeutics","article-title":"Opioid analgesics","author":"Gutstein","year":"2006"},{"key":"10.1016\/j.yrtph.2010.12.007_b0105","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.1016\/0006-2952(88)90065-2","article-title":"A \u03bc-opioid receptor-filter assay. Rapid estimation of binding affinity of ligands and reversibility of long-lasting ligand receptor complexes.","volume":"37","author":"Ilien","year":"1988","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.yrtph.2010.12.007_b0110","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/00002508-200207001-00002","article-title":"Clinical pharmacology of opioids for pain","volume":"18","author":"Inturrisi","year":"2002","journal-title":"Clin. J. Pain."},{"key":"10.1016\/j.yrtph.2010.12.007_b0115","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1124\/jpet.107.119560","article-title":"Pharmacokinetics and pharmacodynamics of seven opioids in P-glycoprotein-competent mice. assessment of unbound brain EC50, u and correlation of in vitro, preclinical, and clinical data","volume":"323","author":"Kalvass","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.yrtph.2010.12.007_b0120","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.clpt.2006.01.009","article-title":"Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: role of circulating active metabolites","volume":"79","author":"Lalovic","year":"2006","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.yrtph.2010.12.007_b0125","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0031-6997(25)06657-8","article-title":"Methods used for the study of opioid receptors","volume":"39","author":"Leslie","year":"1987","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.yrtph.2010.12.007_b0130","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0014-2999(83)90331-X","article-title":"(3H)Sufentanil, a superior ligand for \u03bc-opiate receptors: binding properties and regional distribution in rat brain and spinal cord","volume":"87","author":"Leysen","year":"1983","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.yrtph.2010.12.007_b0135","series-title":"Sax\u2019s Dangerous Properties of Industrial Materials","author":"Lewis","year":"1996"},{"key":"10.1016\/j.yrtph.2010.12.007_b0140","unstructured":"Millipore, 2008. Chemiscreen membrane preparation recombinant human \u03bc (mu) opioid receptor. 09\/30\/08\/HTS101M\/ML\/LA. <http:\/\/www.millipore.com>, accessed 4\/6\/09]."},{"key":"10.1016\/j.yrtph.2010.12.007_b0145","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.pain.2007.03.022","article-title":"Oxycodone and morphine have distinctly different pharmacological profiles: radioligand binding and behavioral studies in two rat models of neuropathic pain","volume":"132","author":"Nielsen","year":"2007","journal-title":"Pain"},{"key":"10.1016\/j.yrtph.2010.12.007_b0150","unstructured":"Office of National Drug Control Policy. Proper disposal of prescription drugs. October 2009. <http:\/\/www.whitehousedrugpolicy.gov\/publications\/pdf\/prescript_disposal.pdf>. Accessed 10\/5\/10."},{"key":"10.1016\/j.yrtph.2010.12.007_b0155","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1124\/jpet.105.094276","article-title":"Comparison of the antinociceptive response to morphine and morphine-like compounds in male and female Sprague-Dawley rats","volume":"316","author":"Peckham","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.yrtph.2010.12.007_b0160","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1021\/ac702060j","article-title":"Fully automated determination in the low nanogram per liter level of different classes of drugs of abuse in sewage water by on-line solid-phase extraction\u2013liquid chromatography-electrospray-tandem mass spectrometry","volume":"80","author":"Postigo","year":"2008","journal-title":"Anal. Chem."},{"key":"10.1016\/j.yrtph.2010.12.007_b0165","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0022-3565(25)11227-5","article-title":"Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an \u2018atypical\u2019 opioid analgesic","volume":"260","author":"Raffa","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.yrtph.2010.12.007_b0170","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0022-3565(25)39454-1","article-title":"Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol","volume":"267","author":"Raffa","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.yrtph.2010.12.007_b0175","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0026-895X(25)09932-8","article-title":"Pharmacological characterization of the cloned \u03ba-, \u03b4-, and \u03bc-opioid receptors","volume":"45","author":"Raynor","year":"1994","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.yrtph.2010.12.007_b0180","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0014-2999(85)90239-0","article-title":"Species differences in the concentrations and distributions of opioid binding sites","volume":"112","author":"Robson","year":"1985","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.yrtph.2010.12.007_b0185","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1023\/A:1015994030251","article-title":"Solubility and related physicochemical properties of narcotics analgesics","volume":"5","author":"Roy","year":"1988","journal-title":"Pharm. Res."},{"key":"10.1016\/j.yrtph.2010.12.007_b0190","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0361-9230(03)00014-5","article-title":"Effect of strain and sex on \u03bc opioid receptor-mediated G-protein activation in rat brain","volume":"60","author":"Selley","year":"2003","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.yrtph.2010.12.007_b0195","first-page":"977","article-title":"Temperature and ionic influences on opiate receptor binding","volume":"12","author":"Simantov","year":"1976","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.yrtph.2010.12.007_b0200","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1046\/j.1460-9568.2003.02744.x","article-title":"Binding characteristics of (3H)14-methoxymetopon, a high affinity mu-opioid receptor agonist","volume":"18","author":"Spetea","year":"2003","journal-title":"Eur. J. Neuroscience."},{"key":"10.1016\/j.yrtph.2010.12.007_b0205","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1467-2995.2006.00337.x","article-title":"Comparison of opioid receptor binding in horse, guinea pig, and rat cerebral cortex and cerebellum","volume":"34","author":"Thomasy","year":"2007","journal-title":"Vet. Anaesth. Analgesia."},{"key":"10.1016\/j.yrtph.2010.12.007_b0210","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0014-2999(89)90582-7","article-title":"\u039c Opiate receptors are selectively labeled by (3H)carfentanil in human and rat brain","volume":"167","author":"Titeler","year":"1989","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.yrtph.2010.12.007_b0215","first-page":"440","article-title":"Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications","volume":"178","author":"Toll","year":"1998","journal-title":"NIDA Res. Monogr."},{"key":"10.1016\/j.yrtph.2010.12.007_b0220","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0026-895X(25)08634-1","article-title":"Modulation by \u03bc-opioid agonists of guanosine-5\u2032-O-(3-(35S)thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells","volume":"47","author":"Traynor","year":"1995","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.yrtph.2010.12.007_b0225","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.36076\/ppj.2008\/11\/S133","article-title":"Opioid pharmacology","volume":"11","author":"Trescott","year":"2008","journal-title":"Pain Physician"},{"key":"10.1016\/j.yrtph.2010.12.007_b0230","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1124\/jpet.107.126052","article-title":"(\u2212)-(1R, 2R)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol hydrochloride (tapentadol HCl): a novel mu-opioid receptor agonist\/norepinephrine reuptake inhibitor with broad-spectrum analgesic properties","volume":"323","author":"Tzschentke","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.yrtph.2010.12.007_b0235","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1146\/annurev.biochem.73.011303.073940","article-title":"Opioid receptors","volume":"73","author":"Waldhoer","year":"2004","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.yrtph.2010.12.007_b0240","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/j.bmcl.2009.02.078","article-title":"Syntheses of novel high affinity ligands for opioid receptors","volume":"19","author":"Wentland","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.yrtph.2010.12.007_b0245","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0028-3908(88)90141-4","article-title":"Comparative binding of \u03bc and \u03b4 selective ligands in whole brain and pons\/medulla homogenates from rat: affinity profiles of fentanyl derivatives","volume":"27","author":"Yeadon","year":"1988","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.yrtph.2010.12.007_b0250","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0014-2999(91)90207-7","article-title":"Species differences in \u03bc- and \u03b4-opioid receptors","volume":"1993","author":"Yoburn","year":"1991","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.yrtph.2010.12.007_b0255","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.watres.2007.09.010","article-title":"Illicit drugs, a novel group of environmental contaminants","volume":"42","author":"Zuccato","year":"2008","journal-title":"Water Res."}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230011000031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230011000031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T09:02:02Z","timestamp":1740819722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230011000031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0273230011000031"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2010.12.007","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}